Congenital Infantile Fibrosarcoma Associated With a Lipofibromatosis-Like Component: One Train May Be Hiding Another

Romain Swiadkiewicz1, Louise Galmiche, Kahina Belhous

  • 1Departments of *Maxillofacial and Plastic Surgery, and †Pathology, Necker Children Hospital, APHP, Paris, France; ‡Paris Descartes University, Paris, France; Departments of §Pediatric Radiology, and ¶Dermatology, Necker Children Hospital, APHP, Paris, France; ‖Laboratory of Solid Tumors Genetics and Central Laboratory of Pathology, Nice University Hospital, Nice, France; **Microenvironment, Signaling and Cancer, INSERM, Université Nice Sophia-Antipolis, Nice, France; ††Molecular Oral Pathology, INSERM, Centre de Recherche de Cordeliers, Paris, France; and ‡‡Adolescent and Pediatric Oncology Department, Institut Curie, Paris, France.

Insights

Congenital infantile fibrosarcoma (CIFS), a rare infant cancer, can present with benign lipofibromatosis-like areas. This unusual combination can delay CIFS diagnosis in children.

Area of Science:

  • Pediatric oncology
  • Soft tissue pathology
  • Developmental biology

Background:

  • Congenital infantile fibrosarcoma (CIFS) is a malignant soft tissue tumor typically affecting infants, primarily in the lower extremities.
  • Lipofibromatosis is a rare, benign infiltrative soft tissue tumor found in children, distinct from CIFS.
  • Accurate diagnosis of pediatric soft tissue tumors is crucial for appropriate management and outcomes.

Observation:

  • This study describes a unique case of CIFS exhibiting surrounding areas resembling lipofibromatosis.
  • The patient presented with a lesion that initially suggested a benign condition due to these lipofibromatous features.

Findings:

  • Histopathological examination revealed a CIFS diagnosis despite the presence of benign-appearing lipofibromatous tissue.
  • The co-occurrence of these distinct entities in a single lesion is rare and poses diagnostic challenges.

Implications:

  • The findings highlight the importance of comprehensive histopathological evaluation for pediatric soft tissue lesions.
  • Recognizing this unusual presentation can help clinicians avoid diagnostic delays and ensure timely treatment for CIFS.
  • Further research may elucidate the biological mechanisms underlying this combined tumor presentation.